当前位置:首页 - 行情中心 - 万泰生物(603392) - 财务分析 - 现金流量表

万泰生物

(603392)

  

流通市值:492.10亿  总市值:492.10亿
流通股本:12.64亿   总股本:12.64亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,438,221,560.561,803,955,458.741,090,752,777.2574,456,759.02
  收到的税费返还1,489,586.8117,053.733,068.483,068.48
  收到其他与经营活动有关的现金139,241,305.72117,080,445.6878,865,735.8254,063,460.64
  经营活动现金流入小计2,578,952,453.091,921,052,958.151,169,621,581.5628,523,288.14
  购买商品、接受劳务支付的现金643,215,533.89419,100,138.2263,620,598.96176,433,601.75
  支付给职工以及为职工支付的现金1,034,628,104.58798,829,410.92574,836,717.51344,074,013.12
  支付的各项税费164,693,486.34107,439,584.9280,202,387.8841,000,836.75
  支付其他与经营活动有关的现金646,661,285.18588,399,269.44317,515,282.71152,987,767.18
  经营活动现金流出小计2,489,198,409.991,913,768,403.481,236,174,987.06714,496,218.8
  经营活动产生的现金流量净额89,754,043.17,284,554.67-66,553,405.56-85,972,930.66
二、投资活动产生的现金流量:
  收回投资收到的现金4,647,311,628.273,984,425,204.452,218,505,7601,678,259,080
  取得投资收益收到的现金114,450,861.91102,983,184.4349,474,203.317,742,951.9
  处置固定资产、无形资产和其他长期资产收回的现金净额210,726,017.0548,990.8544,768.8543,756.46
  收到的其他与投资活动有关的现金5,775,292.24302,022.04--
  投资活动现金流入小计4,978,263,799.474,087,759,401.772,268,024,732.151,696,045,788.36
  购建固定资产、无形资产和其他长期资产支付的现金805,164,493.44557,471,858.41432,022,484.44155,283,188.38
  投资支付的现金4,929,122,930.22923,443.68--
  支付其他与投资活动有关的现金2,985,107.83,606,361,2002,335,361,2001,947,000,000
  投资活动现金流出小计5,737,272,531.464,164,756,502.092,767,383,684.442,102,283,188.38
  投资活动产生的现金流量净额-759,008,731.99-76,997,100.32-499,358,952.29-406,237,400.02
三、筹资活动产生的现金流量:
  取得借款收到的现金343,558,490.81249,073,800.99119,383,754.94-
  收到其他与筹资活动有关的现金-2,851,954.561,214,782.56812,082.56
  筹资活动现金流入小计343,558,490.81251,925,755.55120,598,537.5812,082.56
  偿还债务支付的现金319,007,771.34231,825,639.41160,733,219.517,086,760
  分配股利、利润或偿付利息支付的现金2,277,526.661,314,939.151,082,833.08581,430.98
  支付其他与筹资活动有关的现金21,801,532.27,601,461.635,565,057.081,895,201.35
  筹资活动现金流出小计343,086,830.2240,742,040.19167,381,109.6619,563,392.33
  筹资活动产生的现金流量净额471,660.6111,183,715.36-46,782,572.16-18,751,309.77
四、汇率变动对现金及现金等价物的影响-13,270,093.55-4,670,237.65-891,741.35-233,920.66
五、现金及现金等价物净增加额-682,053,121.83-63,199,067.94-613,586,671.36-511,195,561.11
  加:期初现金及现金等价物余额2,027,005,826.52,027,005,826.52,027,005,826.52,027,005,826.5
  期末现金及现金等价物余额1,344,952,704.671,963,806,758.561,413,419,155.141,515,810,265.39
补充资料:
  净利润-413,963,529.44--145,492,229.78-
  资产减值准备207,361,022.12-23,426,159.84-
  固定资产和投资性房地产折旧262,816,779.48-126,633,472.93-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧262,816,779.48-126,633,472.93-
  无形资产摊销53,278,499.24-19,133,905.37-
  长期待摊费用摊销21,725,256.4-10,394,548.6-
  处置固定资产、无形资产和其他长期资产的损失-60,231,327.31-146,644.6-
  固定资产报废损失2,193,208.09-1,117,276.03-
  公允价值变动损失-48,297,071.98--17,591,273.78-
  财务费用14,660,009.6-3,408,049.43-
  投资损失-66,215,195.97--44,357,628.65-
  递延所得税-94,845,344.69--8,191,106.5-
  其中:递延所得税资产减少-94,845,344.69--8,191,106.5-
  存货的减少-40,540,197.18--110,937,022.61-
  经营性应收项目的减少398,160,460.04-140,006,200.46-
  经营性应付项目的增加-183,403,743.15--142,749,151.44-
  其他-14,145,472.91---
  不涉及现金收支的投资和筹资活动金额其他项目8,341,962.59---
  现金的期末余额1,344,952,704.67-1,413,419,155.14-
  减:现金的期初余额2,027,005,826.5-2,027,005,826.5-
  现金及现金等价物的净增加额-682,053,121.83--613,586,671.36-
公告日期2026-04-212025-10-302025-08-212025-04-25
审计意见(境内)标准无保留意见
TOP↑